Posted By - Investment Banker
Pharma company in the field of manufacturing APIs for Therapeutic drugs and Intermediates, R&D, Custom Synthesis is looking to raise funds to restart its operations. The firm has always focused on complicated chemistries and specialty products and manufactures various Therapeutic drugs including Anti-Parkinson, Anti-Ulcerative, Anti-Asthmatic, Anti Bacterial, etc. The firm has 2 units and to set up a second plant for which they took a loan from Bank but did not get the clearance due to the vested interest of the local government. It took 26 months to get clearance from the Local government. At the same time, an untimely separate state agitation happened and non-co-operation from banks led to the company becoming NPA. That's why sales are 0.
INR 35 Cr
The firm has large domestic and international clients including Pfizer, Ranbaxy, Dr. Reddy, etc.
Private Equity, Strategic Investor
Extent Of Dilution
Upto 49 %
Share Holding Pattern
Non-Promoter Share Holder
Reason For Raising Capital
Entity is open for Investor keen on special situation/distress assets funding
|2017 (in Cr)||2018 (in Cr)||2019 (in Cr)||2020 (in Cr)|